HEADER MEMBRANE PROTEIN 03-JAN-17 5UEN TITLE CRYSTAL STRUCTURE OF THE HUMAN ADENOSINE A1 RECEPTOR A1AR-BRIL IN TITLE 2 COMPLEX WITH THE COVALENT ANTAGONIST DU172 AT 3.2A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENOSINE RECEPTOR A1,SOLUBLE CYTOCHROME B562,ADENOSINE COMPND 3 RECEPTOR A1; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP P30542 REISUES 2-210, UNP P0ABE7 RESIDUES 23-127, UNP COMPND 6 P30542 RESIDUES 228-31,UNP P30542 REISUES 2-210, UNP P0ABE7 RESIDUES COMPND 7 23-127, UNP P30542 RESIDUES 228-31,UNP P30542 REISUES 2-210, UNP COMPND 8 P0ABE7 RESIDUES 23-127, UNP P30542 RESIDUES 228-31; COMPND 9 SYNONYM: CYTOCHROME B-562; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: ADORA1, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS GPCR, TRANSMEMBRANE, RECEPTOR, ADENOSINE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.GLUKHOVA,D.M.THAL,A.T.NGUYEN,E.A.VECCHIO,M.JORG,P.J.SCAMMELLS, AUTHOR 2 L.T.MAY,P.M.SEXTON,A.CHRISTOPOULOS REVDAT 5 04-OCT-23 5UEN 1 REMARK REVDAT 4 08-JAN-20 5UEN 1 REMARK REVDAT 3 27-SEP-17 5UEN 1 REMARK REVDAT 2 15-MAR-17 5UEN 1 JRNL REVDAT 1 01-MAR-17 5UEN 0 JRNL AUTH A.GLUKHOVA,D.M.THAL,A.T.NGUYEN,E.A.VECCHIO,M.JORG, JRNL AUTH 2 P.J.SCAMMELLS,L.T.MAY,P.M.SEXTON,A.CHRISTOPOULOS JRNL TITL STRUCTURE OF THE ADENOSINE A1 RECEPTOR REVEALS THE BASIS FOR JRNL TITL 2 SUBTYPE SELECTIVITY. JRNL REF CELL V. 168 867 2017 JRNL REFN ISSN 1097-4172 JRNL PMID 28235198 JRNL DOI 10.1016/J.CELL.2017.01.042 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0155 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 21759 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.288 REMARK 3 R VALUE (WORKING SET) : 0.286 REMARK 3 FREE R VALUE : 0.316 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1105 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1598 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.17 REMARK 3 BIN R VALUE (WORKING SET) : 0.3660 REMARK 3 BIN FREE R VALUE SET COUNT : 69 REMARK 3 BIN FREE R VALUE : 0.4240 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6061 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 189 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 92.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.32000 REMARK 3 B22 (A**2) : 6.09000 REMARK 3 B33 (A**2) : 0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.553 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.482 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 59.391 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : NULL REMARK 3 ION PROBE RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5UEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000224321. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : SILICON DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23000 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 14.10 REMARK 200 R MERGE (I) : 0.32800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 14.40 REMARK 200 R MERGE FOR SHELL (I) : 2.76700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.6 REMARK 200 STARTING MODEL: 4EIY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH 7.0-8.0, 28-38% PEG REMARK 280 300 AND 500-700 MM NH4F, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 56.48000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.08550 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 56.48000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 62.08550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 PRO A 1 REMARK 465 PRO A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 1014 REMARK 465 LYS A 1015 REMARK 465 VAL A 1016 REMARK 465 ILE A 1017 REMARK 465 GLU A 1018 REMARK 465 LYS A 1019 REMARK 465 ALA A 1020 REMARK 465 ASP A 1021 REMARK 465 ASN A 1022 REMARK 465 ALA A 1023 REMARK 465 ALA A 1024 REMARK 465 GLN A 1025 REMARK 465 GLN A 1041 REMARK 465 LYS A 1042 REMARK 465 ALA A 1043 REMARK 465 THR A 1044 REMARK 465 PRO A 1045 REMARK 465 PRO A 1046 REMARK 465 LYS A 1047 REMARK 465 LEU A 1048 REMARK 465 GLU A 1049 REMARK 465 ASP A 1050 REMARK 465 LYS A 1051 REMARK 465 SER A 1052 REMARK 465 PRO A 1053 REMARK 465 ASP A 1054 REMARK 465 SER A 1055 REMARK 465 GLN A 317 REMARK 465 GLY B 0 REMARK 465 PRO B 1 REMARK 465 PRO B 2 REMARK 465 PRO B 3 REMARK 465 SER B 4 REMARK 465 ILE B 5 REMARK 465 ALA B 1043 REMARK 465 THR B 1044 REMARK 465 PRO B 1045 REMARK 465 PRO B 1046 REMARK 465 LYS B 1047 REMARK 465 LEU B 1048 REMARK 465 GLU B 1049 REMARK 465 ASP B 1050 REMARK 465 LYS B 1051 REMARK 465 SER B 1052 REMARK 465 PRO B 1053 REMARK 465 ASP B 1054 REMARK 465 SER B 1055 REMARK 465 PRO B 1056 REMARK 465 GLU B 1057 REMARK 465 MET B 1058 REMARK 465 LYS B 1059 REMARK 465 ASP B 1060 REMARK 465 PHE B 1061 REMARK 465 GLN B 310 REMARK 465 PRO B 311 REMARK 465 LEU B 312 REMARK 465 GLU B 313 REMARK 465 VAL B 314 REMARK 465 LEU B 315 REMARK 465 PHE B 316 REMARK 465 GLN B 317 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 41 56.18 -99.57 REMARK 500 VAL A 189 -61.70 -108.85 REMARK 500 ARG B 41 56.07 -99.62 REMARK 500 VAL B 189 -62.29 -109.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 1204 REMARK 610 OLA A 1205 REMARK 610 OLA B 1204 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DU1 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 1205 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DU1 B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA B 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA B 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA B 1204 DBREF 5UEN A 2 211 UNP P30542 AA1R_HUMAN 2 211 DBREF 5UEN A 1001 1105 UNP P0ABE7 C562_ECOLX 23 127 DBREF 5UEN A 228 311 UNP P30542 AA1R_HUMAN 228 311 DBREF 5UEN B 2 211 UNP P30542 AA1R_HUMAN 2 211 DBREF 5UEN B 1001 1105 UNP P0ABE7 C562_ECOLX 23 127 DBREF 5UEN B 228 311 UNP P30542 AA1R_HUMAN 228 311 SEQADV 5UEN GLY A 0 UNP P30542 EXPRESSION TAG SEQADV 5UEN PRO A 1 UNP P30542 EXPRESSION TAG SEQADV 5UEN ALA A 159 UNP P30542 ASN 159 ENGINEERED MUTATION SEQADV 5UEN TRP A 1007 UNP P0ABE7 MET 29 CONFLICT SEQADV 5UEN ILE A 1102 UNP P0ABE7 HIS 124 CONFLICT SEQADV 5UEN LEU A 1106 UNP P0ABE7 LINKER SEQADV 5UEN GLU A 220 UNP P0ABE7 LINKER SEQADV 5UEN ARG A 221 UNP P0ABE7 LINKER SEQADV 5UEN ALA A 222 UNP P0ABE7 LINKER SEQADV 5UEN ARG A 223 UNP P0ABE7 LINKER SEQADV 5UEN SER A 224 UNP P0ABE7 LINKER SEQADV 5UEN THR A 225 UNP P0ABE7 LINKER SEQADV 5UEN LEU A 226 UNP P0ABE7 LINKER SEQADV 5UEN GLN A 227 UNP P0ABE7 LINKER SEQADV 5UEN LEU A 312 UNP P30542 EXPRESSION TAG SEQADV 5UEN GLU A 313 UNP P30542 EXPRESSION TAG SEQADV 5UEN VAL A 314 UNP P30542 EXPRESSION TAG SEQADV 5UEN LEU A 315 UNP P30542 EXPRESSION TAG SEQADV 5UEN PHE A 316 UNP P30542 EXPRESSION TAG SEQADV 5UEN GLN A 317 UNP P30542 EXPRESSION TAG SEQADV 5UEN GLY B 0 UNP P30542 EXPRESSION TAG SEQADV 5UEN PRO B 1 UNP P30542 EXPRESSION TAG SEQADV 5UEN ALA B 159 UNP P30542 ASN 159 ENGINEERED MUTATION SEQADV 5UEN TRP B 1007 UNP P0ABE7 MET 29 CONFLICT SEQADV 5UEN ILE B 1102 UNP P0ABE7 HIS 124 CONFLICT SEQADV 5UEN LEU B 1106 UNP P0ABE7 LINKER SEQADV 5UEN GLU B 220 UNP P0ABE7 LINKER SEQADV 5UEN ARG B 221 UNP P0ABE7 LINKER SEQADV 5UEN ALA B 222 UNP P0ABE7 LINKER SEQADV 5UEN ARG B 223 UNP P0ABE7 LINKER SEQADV 5UEN SER B 224 UNP P0ABE7 LINKER SEQADV 5UEN THR B 225 UNP P0ABE7 LINKER SEQADV 5UEN LEU B 226 UNP P0ABE7 LINKER SEQADV 5UEN GLN B 227 UNP P0ABE7 LINKER SEQADV 5UEN LEU B 312 UNP P30542 EXPRESSION TAG SEQADV 5UEN GLU B 313 UNP P30542 EXPRESSION TAG SEQADV 5UEN VAL B 314 UNP P30542 EXPRESSION TAG SEQADV 5UEN LEU B 315 UNP P30542 EXPRESSION TAG SEQADV 5UEN PHE B 316 UNP P30542 EXPRESSION TAG SEQADV 5UEN GLN B 317 UNP P30542 EXPRESSION TAG SEQRES 1 A 416 GLY PRO PRO PRO SER ILE SER ALA PHE GLN ALA ALA TYR SEQRES 2 A 416 ILE GLY ILE GLU VAL LEU ILE ALA LEU VAL SER VAL PRO SEQRES 3 A 416 GLY ASN VAL LEU VAL ILE TRP ALA VAL LYS VAL ASN GLN SEQRES 4 A 416 ALA LEU ARG ASP ALA THR PHE CYS PHE ILE VAL SER LEU SEQRES 5 A 416 ALA VAL ALA ASP VAL ALA VAL GLY ALA LEU VAL ILE PRO SEQRES 6 A 416 LEU ALA ILE LEU ILE ASN ILE GLY PRO GLN THR TYR PHE SEQRES 7 A 416 HIS THR CYS LEU MET VAL ALA CYS PRO VAL LEU ILE LEU SEQRES 8 A 416 THR GLN SER SER ILE LEU ALA LEU LEU ALA ILE ALA VAL SEQRES 9 A 416 ASP ARG TYR LEU ARG VAL LYS ILE PRO LEU ARG TYR LYS SEQRES 10 A 416 MET VAL VAL THR PRO ARG ARG ALA ALA VAL ALA ILE ALA SEQRES 11 A 416 GLY CYS TRP ILE LEU SER PHE VAL VAL GLY LEU THR PRO SEQRES 12 A 416 MET PHE GLY TRP ASN ASN LEU SER ALA VAL GLU ARG ALA SEQRES 13 A 416 TRP ALA ALA ALA GLY SER MET GLY GLU PRO VAL ILE LYS SEQRES 14 A 416 CYS GLU PHE GLU LYS VAL ILE SER MET GLU TYR MET VAL SEQRES 15 A 416 TYR PHE ASN PHE PHE VAL TRP VAL LEU PRO PRO LEU LEU SEQRES 16 A 416 LEU MET VAL LEU ILE TYR LEU GLU VAL PHE TYR LEU ILE SEQRES 17 A 416 ARG LYS GLN LEU ALA ASP LEU GLU ASP ASN TRP GLU THR SEQRES 18 A 416 LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN SEQRES 19 A 416 ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA SEQRES 20 A 416 ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO LYS LEU SEQRES 21 A 416 GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS ASP PHE SEQRES 22 A 416 ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE ASP ASP SEQRES 23 A 416 ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS GLU ALA SEQRES 24 A 416 GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG ASN ALA SEQRES 25 A 416 TYR ILE GLN LYS TYR LEU GLU ARG ALA ARG SER THR LEU SEQRES 26 A 416 GLN LYS GLU LEU LYS ILE ALA LYS SER LEU ALA LEU ILE SEQRES 27 A 416 LEU PHE LEU PHE ALA LEU SER TRP LEU PRO LEU HIS ILE SEQRES 28 A 416 LEU ASN CYS ILE THR LEU PHE CYS PRO SER CYS HIS LYS SEQRES 29 A 416 PRO SER ILE LEU THR TYR ILE ALA ILE PHE LEU THR HIS SEQRES 30 A 416 GLY ASN SER ALA MET ASN PRO ILE VAL TYR ALA PHE ARG SEQRES 31 A 416 ILE GLN LYS PHE ARG VAL THR PHE LEU LYS ILE TRP ASN SEQRES 32 A 416 ASP HIS PHE ARG CYS GLN PRO LEU GLU VAL LEU PHE GLN SEQRES 1 B 416 GLY PRO PRO PRO SER ILE SER ALA PHE GLN ALA ALA TYR SEQRES 2 B 416 ILE GLY ILE GLU VAL LEU ILE ALA LEU VAL SER VAL PRO SEQRES 3 B 416 GLY ASN VAL LEU VAL ILE TRP ALA VAL LYS VAL ASN GLN SEQRES 4 B 416 ALA LEU ARG ASP ALA THR PHE CYS PHE ILE VAL SER LEU SEQRES 5 B 416 ALA VAL ALA ASP VAL ALA VAL GLY ALA LEU VAL ILE PRO SEQRES 6 B 416 LEU ALA ILE LEU ILE ASN ILE GLY PRO GLN THR TYR PHE SEQRES 7 B 416 HIS THR CYS LEU MET VAL ALA CYS PRO VAL LEU ILE LEU SEQRES 8 B 416 THR GLN SER SER ILE LEU ALA LEU LEU ALA ILE ALA VAL SEQRES 9 B 416 ASP ARG TYR LEU ARG VAL LYS ILE PRO LEU ARG TYR LYS SEQRES 10 B 416 MET VAL VAL THR PRO ARG ARG ALA ALA VAL ALA ILE ALA SEQRES 11 B 416 GLY CYS TRP ILE LEU SER PHE VAL VAL GLY LEU THR PRO SEQRES 12 B 416 MET PHE GLY TRP ASN ASN LEU SER ALA VAL GLU ARG ALA SEQRES 13 B 416 TRP ALA ALA ALA GLY SER MET GLY GLU PRO VAL ILE LYS SEQRES 14 B 416 CYS GLU PHE GLU LYS VAL ILE SER MET GLU TYR MET VAL SEQRES 15 B 416 TYR PHE ASN PHE PHE VAL TRP VAL LEU PRO PRO LEU LEU SEQRES 16 B 416 LEU MET VAL LEU ILE TYR LEU GLU VAL PHE TYR LEU ILE SEQRES 17 B 416 ARG LYS GLN LEU ALA ASP LEU GLU ASP ASN TRP GLU THR SEQRES 18 B 416 LEU ASN ASP ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN SEQRES 19 B 416 ALA ALA GLN VAL LYS ASP ALA LEU THR LYS MET ARG ALA SEQRES 20 B 416 ALA ALA LEU ASP ALA GLN LYS ALA THR PRO PRO LYS LEU SEQRES 21 B 416 GLU ASP LYS SER PRO ASP SER PRO GLU MET LYS ASP PHE SEQRES 22 B 416 ARG HIS GLY PHE ASP ILE LEU VAL GLY GLN ILE ASP ASP SEQRES 23 B 416 ALA LEU LYS LEU ALA ASN GLU GLY LYS VAL LYS GLU ALA SEQRES 24 B 416 GLN ALA ALA ALA GLU GLN LEU LYS THR THR ARG ASN ALA SEQRES 25 B 416 TYR ILE GLN LYS TYR LEU GLU ARG ALA ARG SER THR LEU SEQRES 26 B 416 GLN LYS GLU LEU LYS ILE ALA LYS SER LEU ALA LEU ILE SEQRES 27 B 416 LEU PHE LEU PHE ALA LEU SER TRP LEU PRO LEU HIS ILE SEQRES 28 B 416 LEU ASN CYS ILE THR LEU PHE CYS PRO SER CYS HIS LYS SEQRES 29 B 416 PRO SER ILE LEU THR TYR ILE ALA ILE PHE LEU THR HIS SEQRES 30 B 416 GLY ASN SER ALA MET ASN PRO ILE VAL TYR ALA PHE ARG SEQRES 31 B 416 ILE GLN LYS PHE ARG VAL THR PHE LEU LYS ILE TRP ASN SEQRES 32 B 416 ASP HIS PHE ARG CYS GLN PRO LEU GLU VAL LEU PHE GLN HET DU1 A1201 35 HET OLA A1202 20 HET OLA A1203 20 HET OLA A1204 14 HET OLA A1205 12 HET DU1 B1201 35 HET OLA B1202 20 HET OLA B1203 20 HET OLA B1204 13 HETNAM DU1 4-{[3-(8-CYCLOHEXYL-2,6-DIOXO-1-PROPYL-1,2,6,7- HETNAM 2 DU1 TETRAHYDRO-3H-PURIN-3-YL)PROPYL]CARBAMOYL}BENZENE-1- HETNAM 3 DU1 SULFONYL FLUORIDE HETNAM OLA OLEIC ACID FORMUL 3 DU1 2(C24 H30 F N5 O5 S) FORMUL 4 OLA 7(C18 H34 O2) HELIX 1 AA1 SER A 6 ASN A 37 1 32 HELIX 2 AA2 GLN A 38 ARG A 41 5 4 HELIX 3 AA3 ASP A 42 LEU A 61 1 20 HELIX 4 AA4 LEU A 61 GLY A 72 1 12 HELIX 5 AA5 PHE A 77 ILE A 111 1 35 HELIX 6 AA6 ARG A 114 VAL A 119 1 6 HELIX 7 AA7 THR A 120 THR A 141 1 22 HELIX 8 AA8 PRO A 142 GLY A 145 5 4 HELIX 9 AA9 ASN A 148 GLY A 160 1 13 HELIX 10 AB1 GLU A 170 ILE A 175 1 6 HELIX 11 AB2 SER A 176 PHE A 183 1 8 HELIX 12 AB3 PHE A 183 VAL A 189 1 7 HELIX 13 AB4 VAL A 189 ASN A 1013 1 36 HELIX 14 AB5 LYS A 1027 ALA A 1040 1 14 HELIX 15 AB6 GLU A 1057 GLY A 1082 1 26 HELIX 16 AB7 LYS A 1083 TYR A 1101 1 19 HELIX 17 AB8 TYR A 1101 CYS A 260 1 47 HELIX 18 AB9 PRO A 266 ILE A 292 1 27 HELIX 19 AC1 ILE A 292 PHE A 307 1 16 HELIX 20 AC2 CYS A 309 PHE A 316 1 8 HELIX 21 AC3 ALA B 7 ASN B 37 1 31 HELIX 22 AC4 GLN B 38 ARG B 41 5 4 HELIX 23 AC5 ASP B 42 LEU B 61 1 20 HELIX 24 AC6 LEU B 61 GLY B 72 1 12 HELIX 25 AC7 PHE B 77 ILE B 111 1 35 HELIX 26 AC8 ARG B 114 VAL B 119 1 6 HELIX 27 AC9 THR B 120 THR B 141 1 22 HELIX 28 AD1 PRO B 142 GLY B 145 5 4 HELIX 29 AD2 ASN B 148 GLY B 160 1 13 HELIX 30 AD3 GLU B 170 ILE B 175 1 6 HELIX 31 AD4 SER B 176 PHE B 183 1 8 HELIX 32 AD5 PHE B 183 VAL B 189 1 7 HELIX 33 AD6 VAL B 189 LYS B 1019 1 42 HELIX 34 AD7 ASN B 1022 LYS B 1042 1 21 HELIX 35 AD8 HIS B 1063 GLY B 1082 1 20 HELIX 36 AD9 LYS B 1083 TYR B 1101 1 19 HELIX 37 AE1 TYR B 1101 CYS B 260 1 47 HELIX 38 AE2 PRO B 266 ILE B 292 1 27 HELIX 39 AE3 ILE B 292 PHE B 307 1 16 SHEET 1 AA1 2 THR A 75 TYR A 76 0 SHEET 2 AA1 2 VAL A 166 ILE A 167 -1 O ILE A 167 N THR A 75 SHEET 1 AA2 2 THR B 75 TYR B 76 0 SHEET 2 AA2 2 VAL B 166 ILE B 167 -1 O ILE B 167 N THR B 75 SSBOND 1 CYS A 80 CYS A 169 1555 1555 2.02 SSBOND 2 CYS A 260 CYS A 263 1555 1555 2.04 SSBOND 3 CYS B 80 CYS B 169 1555 1555 2.04 SSBOND 4 CYS B 260 CYS B 263 1555 1555 2.04 LINK OH TYR A 271 S DU1 A1201 1555 1555 1.61 LINK OH TYR B 271 S DU1 B1201 1555 1555 1.61 SITE 1 AC1 13 TYR A 12 ASN A 70 VAL A 87 LEU A 88 SITE 2 AC1 13 THR A 91 PHE A 171 GLU A 172 MET A 180 SITE 3 AC1 13 TRP A 247 LEU A 250 ASN A 254 TYR A 271 SITE 4 AC1 13 ILE A 274 SITE 1 AC2 4 ALA A 125 VAL A 137 PHE A 144 OLA A1203 SITE 1 AC3 4 CYS A 46 VAL A 49 ILE A 89 OLA A1202 SITE 1 AC4 3 ILE A 5 ALA A 7 LEU A 18 SITE 1 AC5 4 PHE A 8 ASN A 70 ILE A 268 TYR A 271 SITE 1 AC6 11 TYR B 12 VAL B 87 LEU B 88 THR B 91 SITE 2 AC6 11 PHE B 171 MET B 180 TRP B 247 LEU B 250 SITE 3 AC6 11 ASN B 254 TYR B 271 ILE B 274 SITE 1 AC7 4 ALA B 125 PHE B 136 VAL B 137 OLA B1203 SITE 1 AC8 4 VAL B 49 ILE B 89 TRP B 132 OLA B1202 SITE 1 AC9 2 ALA B 10 VAL B 17 CRYST1 96.492 112.960 124.171 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010364 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008853 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008053 0.00000